SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Cardiovascular Disease Market is Expected to Grow Moderately by 2019

[January 03, 2014]

Cardiovascular Disease Market is Expected to Grow Moderately by 2019

(M2 PressWIRE Via Acquire Media NewsEdge) Dublin - Research and Markets (http://www.researchandmarkets.com/research/c4zdd8/cardiovascular) has announced the addition of the "Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat" report to their offering.


The global market for Cardiovascular Disease (CVD) - comprising Heart Failure (HF), Myocardial Infarction and Acute Coronary Syndrome (ACS) - has registered modest growth from 2007-2012 due to the launch of various blockbuster drugs. The market is expected to continue to grow at a moderate rate over the 2012-2019 forecast period, due to the patent expiry of a number of blockbuster drugs, including Lipitor (atorvastatin) and Plavix (clopidogrel).

The value of the CVD market in the US is the highest of the countries covered in this report, amounting to an estimated $6.1 billion in 2012 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.7% over the forecast period to reach $8.49 billion in 2019. The market for all geographies (US, UK, Germany, France, Spain, Italy, Canada and Japan) totaled $13.7 billion in 2012 and is expected to grow at a CAGR of 4.1% to reach $18.2 billion in 2019.

Europe and North America are the Favorable Regions for Co-development Deals in the Cardiovascular Market Of the countries covered in this report, those of Europe and North America countries were preferred by pharmaceutical players for the purposes of conducting co-development deals in the cardiovascular market during the 2007-2013 period. The vast majority of these deals - around 81% - took place exclusively in this region during this period.

The fiscal year ended 2009 accounted for the highest share of co-development deals in terms of volume, with a total of $8 billion, equivalent to around 64% of the total value of all co-development deals for all three cardiovascular indications.

Key Topics Covered: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Therapeutic Landscape 4 Marketed Products 5 Pipeline Analysis 6 Cardiovascular Diseases Global Market to 2019, Market Forecast 7 Deals and Strategic Consolidations 8 Appendix List of Tables List of Figures For more information visit http://www.researchandmarkets.com/research/c4zdd8/cardiovascular About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: Research and Markets, Laura Wood, Senior Manager.

press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Healthcare and Medical Devices (http://www.researchandmarkets.com/categories.asp?cat_id=12&campaign_id=c4zdd8), Pharmaceuticals (http://www.researchandmarkets.com/categories.asp?cat_id=16&campaign_id=c4zdd8) ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to info@m2.com)).

(c) 2014 M2 COMMUNICATIONS

[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy